Maintain deep scientific and competitive knowledge across internal portfolio projects, external opportunities, and emerging assets - spanning discovery through clinical development and platforms - and represent Lilly's strategic and external innovation priorities externally, including industry roundtables, invited presentations, and strong networks across biotech, venture, and pharma. Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women's Initiative for Leading at Lilly (WILL).